CNBC - William Blair Intitates SRPT to Outperform $ 52 Target. $52 !!!! LINK
CNBC MARKET INSIDER
After-Hours Buzz: ADBE, WSM, CTAS & More Published: Tuesday, 19 Mar 2013 | 4:40 PM ET
By: JeeYeon Park
Sarepta Therapeutics - William Blair initiated coverage of the medical research and drug development company with an "outperform" rating and a price target of $52, sending shares higher in extended-hours trading..